Diagnosis: Nodular melanoma
A 57-year-old male presents with a rapidly growing black dome-shaped nodule on his back, which he noticed enlarging over the past month. The lesion is asymptomatic but has raised concerns due to its sudden change in size and appearance, prompting further evaluation.
A 57-year-old male presents with a rapidly growing black dome-shaped nodule on his back, which has been enlarging over the past month. The patient reports no pain or itching associated with the lesion. On examination, the nodule is firm, raised, and exhibits irregular borders with a smooth surface.Size: Approximately 1.5 cm in diameter.Color: Dark black with some areas of brown.Surface: Smooth and shiny.Border: Irregular and poorly defined.Surrounding skin: No signs of inflammation or ulceration.
The patient first noticed the lesion approximately one month ago, describing it as a small bump that has rapidly increased in size. He has no history of trauma or sunburn in the area. His past medical history is significant for hypertension and hyperlipidemia, for which he takes lisinopril and atorvastatin. There is no family history of skin cancer. He is an avid golfer and spends considerable time outdoors without consistent sunscreen use.Onset: Rapid enlargement over the last month.Prior treatments: No prior treatments for the lesion.Past medical history: Hypertension and hyperlipidemia.Family history: No significant history of skin cancer.Social history: Regular outdoor activity, minimal sunscreen use.
Acute / First-Line ManagementComplete surgical excision with clear margins is the primary treatment for localized lesions. The recommended margin is typically 1-2 cm depending on the thickness of the melanoma.For lesions >1 mm in thickness, consider lymph node evaluation and sentinel lymph node biopsy.Workup and Diagnostic ConfirmationHistopathological examination of the excised tissue is essential for diagnosis, with confirmation of melanoma subtype and Breslow thickness.Consider imaging studies (e.g., chest X-ray, CT scan) for staging in cases with high-risk features.Long-Term ManagementRegular follow-up every 3-6 months for the first 2-3 years, then annually thereafter, with skin examinations and education on self-monitoring for new lesions.Adjuvant therapy may be considered for advanced disease, including immune checkpoint inhibitors (e.g., pembrolizumab) or targeted therapies for BRAF-mutant tumors.
Basal Cell Carcinoma: Typically presents as a pearly nodule, often with telangiectasia, and is less likely to be dome-shaped and uniformly dark.Squamous Cell Carcinoma: May present as a firm, red nodule; often associated with sun-damaged skin and does not usually have a dome shape.Dermatofibroma: A benign fibrous tumor that usually presents as a firm, brownish nodule and exhibits a characteristic dimple sign upon lateral compression.Melanocytic Nevus: Typically uniform in color and smaller in size; does not show rapid enlargement or irregular borders.Seborrheic Keratosis: Often appears as a waxy, stuck-on lesion with a varied color palette; not typically dome-shaped.Pyogenic Granuloma: A rapidly growing, red, vascular lesion often associated with trauma; usually not black or dome-shaped.Angiosarcoma: A rare vascular tumor that can present as a nodule but is more aggressive and often involves other systemic symptoms.Kaposi Sarcoma: Vascular tumor associated with immunosuppression, presenting as purple or brown lesions; less likely in an otherwise healthy individual.
High-Yield PearlsRapid Growth: Any rapidly growing pigmented lesion should raise suspicion for melanoma, particularly in older adults.Irregular Borders: Lesions with irregular borders and multiple colors are concerning for malignancy.Histopathology: Definitive diagnosis of melanoma requires histopathological confirmation to assess subtype and thickness.Follow-Up: Regular follow-up is crucial for early detection of recurrence or new primary melanomas.Patient Education: Patients should be educated on skin self-examination techniques and the importance of sun protection.Early recognition and intervention are key to improving outcomes in melanoma.
Tags: nodular melanoma, melanoma